Implementation Guide CH VACD
5.0.0 - trial-use
Implementation Guide CH VACD
5.0.0 - trial-use
This page is part of the CH VACD (R4) (v5.0.0: STU 5) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Generated Narrative: Immunization TCB05-IMMUN1
Author of the content: PractitionerRole
CH VACD Extension Immunization Medication Reference: Medication FSME-IMMUN CC Inj Susp sep Nadel
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/urn:uuid:4386ca26-6866-4322-a203-b488b84ab499
status: Completed
vaccineCode: FSME-Immun CC
patient: Lea Knecht Female, DoB: 1992-05-14 ( Medical record number)
occurrence: 2021-06-22
recorded: 2021-06-22 11:00:00+0200
lotNumber: 12-34244
route: Intramuscular use
| Actor |
| PractitionerRole |
| TargetDisease | DoseNumber[x] |
| Tickborne encephalitis | 1 |